Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/69187
Full metadata record
DC FieldValueLanguage
dc.creatorAugusto Cesar Soares dos Santos Juniorpt_BR
dc.creatorLuíza de Oliveira Rodriguespt_BR
dc.creatorDaniela Castelo Azevedopt_BR
dc.creatorLélia Maria de Almeida Carvalhopt_BR
dc.creatorMariana Ribeiro Fernandespt_BR
dc.creatorSandra de Oliveira Sapori Avelarpt_BR
dc.creatorMaria da Glória Cruvinel Hortapt_BR
dc.creatorSilvana Márcia Bruschi Kellespt_BR
dc.date.accessioned2024-06-13T22:35:38Z-
dc.date.available2024-06-13T22:35:38Z-
dc.date.issued2017-
dc.citation.volume43pt_BR
dc.citation.issue1pt_BR
dc.citation.spage150pt_BR
dc.citation.epage154pt_BR
dc.identifier.doihttps://doi.org/10.1590/S1677-5538.IBJU.2016.0244pt_BR
dc.identifier.issn1677-6119pt_BR
dc.identifier.urihttp://hdl.handle.net/1843/69187-
dc.description.resumoThis study aimed to retrospectively evaluate a cohort of patients with prostate cancer and persistent urinary incontinence after radical prostatectomy. From January 2004 to December 2015, eighty-six individuals were identified to have received an AUS implant, provided by a private nonprofit HMO operating in Belo Horizonte, Brazil. On total, there were 91 AUS implants, with a median interval between radical prostatectomy and AUS implant of 3.6 years (IQR 1.9 to 5.5). The rate of AUS cumulative survival, after a median follow-up of 4.1 years (IQR 1.7-7.2 years), was 44% (n=40). The median survival of AUS implants was 2.9 years (IQR 0.5-7.9 years). Thirty-seven AUS implants (40.7%) resulted in grade III surgical complications. There were 5 deaths at 2.1, 4.7, 5.7, 5.7 and 6.5 years of follow-up, but none due to causes directly associated to the AUS implant. Persistent severe incontinence was documented in 14 (15.3%) additional patients. From the 51 AUS implants which resulted in grade III surgical complications or persistent severe incontinence, 24 (47.1%) underwent surgical revisions. Explantation of the sphincter or its components was observed in 6 cases (25.0%). Mechanical failure, described as fluid loss and/or inability to recycle the AUS device, was observed in 4 devices (16.7%). In conclusion, although AUS implants are recommended as the gold-standard treatment of severe urinary incontinence after prostatectomy, the observed high rates of malfunction and grade III adverse events are a matter of concern warranting further assessment on the safety and efficacy of these devices.pt_BR
dc.format.mimetypepdfpt_BR
dc.languageengpt_BR
dc.publisherUniversidade Federal de Minas Geraispt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentMEDICINA - FACULDADE DE MEDICINApt_BR
dc.publisher.initialsUFMGpt_BR
dc.relation.ispartofInternational Brazilian Journal of Urologypt_BR
dc.rightsAcesso Abertopt_BR
dc.subjectUrinary Incontinencept_BR
dc.subjectProstatectomypt_BR
dc.subjectProstatic Neoplasmspt_BR
dc.subjectUrinary Sphincterpt_BR
dc.subjectArtificialpt_BR
dc.subject.otherNeoplasias da Próstatapt_BR
dc.subject.otherNeoplasiaspt_BR
dc.subject.otherProstatectomiapt_BR
dc.subject.otherIncontinência Urináriapt_BR
dc.titleArtificial urinary sphincter for urinary incontinence after radical prostatectomy: a historical cohort from 2004 to 2015pt_BR
dc.typeArtigo de Periódicopt_BR
dc.url.externahttps://www.scielo.br/j/ibju/a/dbQcBJZ99QbBLg3pV9XRXHh/?lang=enpt_BR
Appears in Collections:Artigo de Periódico



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.